-
Publications
-
Molecular profile of micropapillary urothelial carcinoma of the urinary bladder: An analysis of 99 cases by next-generation sequencing.
Shen Y, Zheng L, Zhao J, Wang Y, Chen H, Roy-Chowdhuri S, Kamat AM, Alhalabi O, Gao J, Siefker-Radtke A, Wei P, Hansel DE, Czerniak B, Guo CC, Human pathology 2025 May 159 105812 -
CIC-rearranged sarcoma in the breast: A series of 3 rare cases with literature review.
Zheng L, He LJ, Chen H, Ding Q, Bishop J, Peng Y, Human pathology 2025 May 105801 -
Differential Outcomes in Bladder Cancer After Neoadjuvant Chemotherapy: An International Multi-Institutional Study Comparing Isolated Nodal Disease vs Persistent Muscle-Invasive Disease.
Acosta AM, Saad M, Chaux A, Gordetsky JB, Zheng L, Guo C, Bikhet M, Osunkoya AO, Collins K, Idrees MT, van Leenders GJLH, Gonzalez-Peramato P, Cornejo KM, Hirsch MS, Kao CS, Matoso A, Magi-Galluzzi C, Rais-Bahrami S, Urology 2025 Apr -
Clinicopathological study of 34 cases of clear cell adenocarcinoma of the urinary tract and diagnostic value of SOX 17 in its differential diagnosis.
Zheng L, Tabet G, Guo CC, Rizvi YO, Raso MG, Liu J, Ding Q, Baraban E, Zhao J, Human pathology 2025 Mar 157 105767 -
Epithelioid trophoblastic tumor in male patients with germ cell tumor: A clinicopathologic analysis of five cases.
Tabet GC, Zheng L, Hosseini H, Ward J, Pisters L, Campbell MT, Tu SM, Czerniak B, Guo CC, Human pathology 2024 Oct 105673 -
Plasmacytoid urothelial carcinoma of the urinary bladder-A clinicopathological and molecular analysis of 52 cases.
Zheng L, Chen H, Zhao J, Roy-Chowdhuri S, Kamat AM, Alhalabi O, Gao J, Siefker-Radtke A, Hansel DE, Czerniak B, Guo CC, Human pathology 2024 Jun 148 1-6 -
Intragenic EGFR::EGFR.E1E8 Fusion (EGFRvIII) in 4331 Solid Tumors.
Zheng L, Luthra R, Alvarez HA, San Lucas FA, Duose DY, Wistuba II, Fuller GN, Ballester LY, Roy-Chowdhuri S, Sweeney KJ, Rashid A, Yang RK, Chen W, Liu A, Wu Y, Albarracin C, Patel KP, Routbort MJ, Sahin AA, Ding Q, Chen H, Cancers 2023 Dec 16 1 -
Two Cases of Biphasic Synovial Sarcoma With Expression of PAX8 and ER: A Diagnostic Pitfall.
Zheng L, Wang XI, Chen S, Moosvi AM, Wan DQ, Zhang S, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists 2023 May 42 3 234-240 -
Invasive Lobular Carcinoma Mimicking Encapsulated Papillary Carcinoma with a Literature Review: A Rare Variant Detected Serendipitously.
Zheng L, Saluja K, Guo T, International journal of surgical pathology 2022 Dec 30 8 912-920 -
Is conservative management of ductal carcinoma in situ risky?
Zheng L, Gökmen-Polar Y, Badve SS, NPJ breast cancer 2022 Apr 8 1 55 -
Gastrointestinal stromal tumors (GISTs) arising in uncommon locations: clinicopathologic features and risk assessment of esophageal, colonic, and appendiceal GISTs.
Hu S, Alpert L, Cates JMM, Gonzalez RS, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2022 Apr 35 4 554-563 -
The value of SOX2 in the differential diagnosis of SMARCA4 (BRG1)-deficient uterine neoplasms.
Zhang L, Zhang L, Wang XI, Katz G, Tandon N, Zhao B, Lucci J, Ding J, Zhang S, Human pathology 2022 Mar -
Myelodysplastic syndrome with t(6;9)(p22;q34.1)/DEK-NUP214 better classified as acute myeloid leukemia? A multicenter study of 107 cases.
Fang H, Yabe M, Zhang X, Kim Y, Wu X, Wei P, Chi S, Zheng L, Garcia-Manero G, Shao L, Yuan J, Shen Y, Zheng G, Tang G, Wang W, Loghavi S, Shen Q, Yuan Y, He R, Chen D, Medeiros LJ, Hu S, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2021 Jun 34 6 1143-1152 -
Philadelphia chromosome-positive B-lymphoblastic lymphoma involving the genitourinary system and bone at initial diagnosis and relapse.
Zheng L, Hu S Blood 2017 Sep 130 12 1483 -
Erratum to: Role of complexity of variant Philadelphia chromosome in chronic myeloid leukemia in the era of tyrosine kinase inhibitor therapy.
Gong Z, Zheng L, Tang Z, Chen Z, Wang W, Bai S, Tang G, Medeiros LJ, Hu S Annals of hematology 2017 May -
Differential depth of treatment response required for optimal outcome in patients with blast phase versus chronic phase of chronic myeloid leukemia.
Chen Z, Medeiros LJ, Kantajian HM, Zheng L, Gong Z, Patel KP, Xiong H, Wang W, Cortes JE, Hu S Blood cancer journal 2017 Feb 7 2 e521 -
Suppression of mir-200 family expression by oncogenic KRAS activation promotes cell survival and epithelial-mesenchymal transition in KRAS-driven cancer.
Zhong X, Zheng L, Shen J, Zhang D, Xiong M, Zhang Y, He X, Tanyi JL, Yang F, Montone KT, Chen X, Xu C, Xiang AP, Huang Q, Xu X, Zhang L Molecular and cellular biology 2016 Aug -
The Heterochronic microRNA let-7 Inhibits Cell Motility by Regulating the Genes in the Actin Cytoskeleton Pathway in Breast Cancer.
Hu X, Guo J, Zheng L, Li C, Zheng TM, Tanyi JL, Liang S, Benedetto C, Mitidieri M, Katsaros D, Zhao X, Zhang Y, Huang Q, Zhang L Molecular cancer research : MCR 2013 Mar 11 3 240-50
-
Molecular profile of micropapillary urothelial carcinoma of the urinary bladder: An analysis of 99 cases by next-generation sequencing.
Lan Zheng, M.D., Ph.D.
- Pathology
Education & Training
- Medical Education - West China Medical Center/Sichuan University/Chengdu (2002-2007)
- Residency - Indiana University (2018-2020), Pathology
- Residency - University of Texas Health Science Center at Houston (2020-2022), Pathology
- Other - University of Texas MD Anderson Cancer Center (2022-2023)
- Fellowship - University of Texas MD Anderson Cancer Center (2022-2023), Pathology
- Fellowship - University of Texas MD Anderson Cancer Center (2023-2024)